JP2014185126A - Transparent liquid composition for oral cavity - Google Patents

Abstract

PROBLEM TO BE SOLVED: To provide a transparent liquid composition for an oral cavity which can exhibit an excellent prevention effect on dental plaque formation by further enhancing an adsorption effect of cetylpyridinium chloride, which has excellent antimicrobial activity against oral bacteria, to tooth surface.SOLUTION: The transparent liquid composition for an oral cavity according to the invention is characterized by containing each specified amount of component (a): cetylpyridinium chloride, component (b): polyoxyethylene hardened castor oil in which an average addition mole number of ethylene oxide is 10 or more and 30 or less, component (c): menthol, and component (d): water system solvent.

Description

  The present invention is a liquid composition for oral cavity that is excellent in the effect of adsorbing cetylpyridinium chloride, which is a medicinal component, on the tooth surface and oral mucosa and can effectively suppress plaque formation, caries and gingivitis It is about things.

  Cetylpyridinium chloride is a cationic bactericidal agent having an excellent bactericidal action, exhibits a high bactericidal effect against oral bacteria, and adsorbs to the tooth surface and oral mucosa. As a result, oral bacteria attached to these can be effectively sterilized and plaque formation can be suppressed.

  In general, menthol is blended in an oral composition for the purpose of improving the feeling of use. Since menthol is an oil-soluble compound that is only slightly soluble in water, it is necessary to use a surfactant in order to stably disperse in water.

  In addition to menthol, the surfactant is used to stably disperse these substances in an aqueous solvent when an oil-soluble fragrance, a medicinal agent, or an insoluble powder such as an abrasive is blended. Further, since the surfactant is adsorbed by these insoluble powders, it is necessary to add a large amount to compensate for it.

  On the other hand, since cetylpyridinium chloride has a high water solubility, it is stably dissolved even in an aqueous solution in which no surfactant is present, and exhibits bactericidal power according to the blended amount. However, it is also known that when a surfactant having a micelle-forming concentration or more is present, cetylpyridinium chloride that has been stably dissolved in water is taken into the micelle and the effectiveness as a bactericide is reduced.

  Therefore, it is necessary to further enhance the adsorptivity of cetylpyridinium chloride to teeth and oral mucosa.

  Accordingly, a liquid oral preparation for preventing plaque formation comprising cetylpyridinium chloride, the above oil-soluble component, and a nonionic surfactant (solubilizing agent) for solubilizing the oil-soluble component, Various proposals have been made on solubilizers that can effectively exhibit the adsorption effect of a cationic fungicide such as cetylpyridinium.

  For example, in Patent Document 1, a preparation in which polyoxyethylene hydrogenated castor oil having an average addition mole number of ethylene oxide of 40 to 80 is mixed with cetylpyridinium chloride does not inhibit adsorption of cetylpyridinium chloride to teeth, It is disclosed that not only is it excellent in preventing plaque formation and preventing dental caries, but it is also excellent in low-temperature stability when held at -5 ° C for 48 hours.

  Further, in Patent Document 2, the antibacterial activity of cetylpyridinium chloride can be stably maintained by blending a polyoxyethylene / polyoxypropylene copolymer in which cetylpyridinium chloride is hardly incorporated into micelles as a solubilizer. An oral composition is disclosed.

  Patent Document 3 discloses a polyethylene glycol fatty acid monoester having an average addition mole number of cetylpyridinium chloride and ethylene oxide of 30 to 55 and / or a polyoxyethylene hydrogenated castor oil having an average addition mole number of ethylene oxide of 90 to 120 The composition for oral cavity which prevented the fall of the antibacterial effect of the cetyl pyridinium chloride by surfactant by mix | blending is disclosed.

  Further, Patent Document 4 and Patent Document 5 do not disclose specific examples of cetylpyridinium chloride, but disclose a technique for enhancing the bactericidal effect of a cationic bactericide.

  Among them, Patent Document 4 discloses that in a composition for oral cavity containing a cationic fungicide and an oil-soluble fragrance, the sugar fatty acid ester has a function of dramatically improving the amount of adsorption of the cationic fungicide on the teeth. Then, in view of the knowledge, it is cationic by combining the sugar fatty acid ester and one or more selected from the group consisting of polyglycerin fatty acid ester, polyoxyethylene hydrogenated castor oil and sorbitan fatty acid ester. It is disclosed that the adsorbability of a bactericide on teeth and the like is improved.

  Further, Patent Document 5 discloses that an oral composition containing a cationic fungicide and an oil-soluble fragrance is solubilized with a polyglycerin fatty acid ester to have a specific emulsion particle size, thereby sterilizing the cationic fungicide. A liquid oral composition that improves the adsorptive power to teeth without reducing the effect is disclosed.

  Patent Document 6 discloses a dentifrice composition that is suppressed from adsorbing to a container inner layer after long-term storage of a poorly water-soluble nonionic medicinal ingredient, has sufficient foaming power and excellent usability, A composition comprising polyoxyethylene hydrogenated castor oil having an average added mole number of ethylene oxide of 5 to 30 is disclosed.

  Patent Document 7 discloses that toothpaste that has been suppressed in adsorption to the inner layer of the container after long-term storage of vitamin E and its derivatives, has excellent appearance stability, has sufficient foaming power, is easy to manufacture, and has a good taste. An agent composition comprising polyoxyethylene hydrogenated castor oil having an average added mole number of ethylene oxide of 10 to 80 is disclosed.

  Patent Document 8 discloses a dentifrice composition that exhibits long-term stability of an ascorbic acid phosphate and is excellent in use feeling.

JP-A-4-173728 JP-A-4-202121 JP 7-215830 A JP 2006-143710 A JP 2009-96724 A Japanese Patent Laid-Open No. 2004-250381 JP 2005-247786 A JP 2011-6351 A

  In order to enhance the adsorption ability of cetylpyridinium chloride to the tooth surface and the like, and to suppress the adsorption of oil-soluble components to the inner layer of the container, various methods relating to solubilizers (nonionic surfactants) are available. Although it is known, there is a demand for further improvement in the ability to adsorb cetylpyridinium chloride on the tooth surface.

  The present invention has been made in view of the above circumstances, and its purpose is to further enhance the effect of adsorbing cetylpyridinium chloride having excellent antibacterial activity against oral bacteria on the tooth surface, etc. An object of the present invention is to provide a transparent liquid composition for oral cavity that can exhibit an anti-formation action.

  The inventors of the present invention have made extensive studies to solve the above problems. As a result, in a liquid composition containing substantially no insoluble powder raw material, when cetylpyridinium chloride and an amount of menthol that gives a good feeling of use as an oral composition are blended, an average of ethylene oxide as a surfactant It has been found that by using polyoxyethylene hydrogenated castor oil with a small number of added moles, these can be stably dispersed in an aqueous solvent, and the adsorptivity of cetylpyridinium chloride to teeth and the like is further increased. It was.

  When polyoxyethylene hydrogenated castor oil is selected as a solubilizer, Patent Document 1 shows experimental data that the amount of cetylpyridinium chloride adsorbed on the tooth surface increased as the average added mole number of ethylene oxide increased. However, the above findings are contrary to this. The reason for this is that when menthol is dispersed in an aqueous solvent while using polyoxyethylene hydrogenated castor oil having a low HLB value at a comparatively low dose, the uptake of cetylpyridinium chloride into the micelle is suppressed, It is considered that it is liberated without being excessively stabilized and adsorbed onto the teeth.

The transparent liquid composition for oral cavity according to the present invention comprises the following components (a), (b), (c) and (d).
Component (a): 0.01% by mass or more and 0.3% by mass or less of cetylpyridinium chloride Component (b): 0.01% by mass or more and 0.4% by mass or less of ethylene oxide having an average added mole number of 10 30 or less polyoxyethylene hydrogenated castor oil Component (c): 0.01% by mass or more and 1.0% by mass or less menthol Component (d): 60% by mass or more and 99.8% by mass or less aqueous solvent

It is preferable to further blend the following component (e) into the transparent liquid composition for oral cavity according to the present invention.
Component (e): Polyoxyethylene hydrogenated castor oil having an average addition mole number of ethylene oxide of not less than 0.01% by mass and not more than 0.3% by mass and not more than the blending amount of component (b) of 40 to 100 Component (e) is an effective component for stably dispersing the oil-soluble component in the composition and maintaining transparency.

  In the transparent liquid composition for oral cavity according to the present invention, the total ratio of the component (b) and the component (e) to the component (a) ([component (b) + component (e)] / component (a)). Is preferably adjusted to 0.6 or more and 4.4 or less. If the said ratio exists in the said range, component (a) is in a micelle, maintaining the transparency of a composition by carrying out the stable dispersion | distribution of the component (a) (cetyl pyridinium chloride) and an oil-soluble component more reliably in a composition. Therefore, it is possible to more effectively suppress the reduction in the amount of adsorption to the teeth and the like due to excessive stabilization.

The transparent liquid composition for oral cavity according to the present invention may further contain the following component (f) which is an oil-soluble component other than the component (c).
Component (f): One or more oil-soluble ingredients selected from oil-soluble medicinal ingredients, oil-soluble fragrances other than menthol, oil-soluble alcohols, and oil-soluble preservatives

  If the transparent liquid composition for oral cavity of the present invention is used, the adsorption effect of cetylpyridinium chloride on the tooth surface and oral mucosa is further promoted, so that the adsorption of oral bacteria causing caries, periodontal disease and the like is inhibited. In addition, it is possible to more effectively suppress plaque formation. Moreover, since the liquid composition of this invention is transparent and is excellent in the external appearance property as an oral preparation, it is used suitably as oral liquid preparations, such as a mouthwash and a bactericidal spray.

  The composition for oral cavity according to the present invention is transparent and liquid, and does not substantially contain insoluble components. Examples of the insoluble component include abrasives such as calcium hydrogen phosphate powder, calcium carbonate powder, anhydrous silicate powder, and hydrous silicate powder. Moreover, it shall mean that it is 0.5 mass% or less with respect to the whole composition, for example not containing substantially.

  Hereinafter, each component of the transparent liquid composition for oral cavity according to the present invention will be described.

Component (a): Cetylpyridinium chloride Cetylpyridinium chloride used in the present invention is a cationic fungicide classified as a quaternary ammonium compound, especially against oral bacteria that cause caries and gingivitis Since it shows a high bactericidal effect, it is widely used as a medicinal component of oral compositions.

  The content of cetylpyridinium chloride with respect to the total amount of the composition according to the present invention is 0.01% by mass or more and 0.3% by mass or less. If the said ratio is 0.01 mass% or more, the intraoral effect of cetyl pyridinium chloride can fully be exhibited. On the other hand, if the ratio is too high, problems such as bitterness during use due to cetylpyridinium chloride may occur. Therefore, the ratio is preferably 0.3% by mass or less. As the said ratio, 0.02 mass% or more is preferable, 0.03 mass% or more is more preferable, 0.04 mass% or more is further more preferable, 0.2 mass% or less is preferable, 0.1 mass% The following is more preferable, and 0.08% by mass or less is more preferable.

Component (b): Polyoxyethylene hydrogenated castor oil having an average added mole number of ethylene oxide of 10 or more and 30 or less The component (b) is a medicinal component while solubilizing menthol, which is an essential component of the composition of the present invention. A certain cetylpyridinium chloride is an important component that enhances the adsorptivity to teeth and oral mucosa without excessive stabilization in micelles.

If the average added mole number of ethylene oxide in the component (b) is 30 or less, the affinity with cetylpyridinium chloride does not become excessive, and the adsorption from the composition to teeth and the like can be promoted remarkably. On the other hand, if the average added mole number is 10 or more, even in the oral composition mainly composed of water, the solubilizing ability to menthol, which is an essential component of the present invention, is sufficient, and the layer separation is suppressed. The composition has good appearance properties. In addition, the said average addition mole number should just refer to the catalog value etc. of the product of polyoxyethylene hydrogenated castor oil. Alternatively, it can be measured by gel filtration using HPLC, ¹ H-NMR and MALDI-MS.

  Content of the component (b) with respect to the composition whole quantity based on this invention shall be 0.01 mass% or more and 0.4 mass% or less. If the said ratio is 0.01 mass% or more, each component can be solubilized more reliably in the composition, and a composition having no phase separation and excellent in appearance properties can be obtained. On the other hand, if the ratio is too high, the amount of cetylpyridinium chloride taken into the micelle tends to increase, so that the amount of cetylpyridinium chloride adsorbed on the teeth tends to be reduced. .4% by mass or less. As the said ratio, 0.02 mass% or more is preferable, 0.05 mass% or more is more preferable, 0.3 mass% or less is preferable, 0.25 mass% or less is more preferable, 0.2 mass% The following is more preferable.

Component (c): Menthol In the composition of the present invention, menthol can give a refreshing feeling during use of the composition and can significantly improve palatability, and is frequently used in oral compositions. It is a perfume ingredient. In addition, although the mechanism of action is not always clear, when polyoxyethylene hydrogenated castor oil having an average addition mole number of ethylene oxide of 10 or more and 30 or less is used as a surfactant, cetylpyridinium chloride, which is a medicinal component, is used. There is also the possibility of showing the effect of increasing the adsorptivity to the teeth and oral mucosa.

  Menthol has three asymmetric carbon atoms in its chemical structure and has eight isomers, but it is preferable to use l-menthol that can most effectively emit a refreshing mint odor. .

  The content of menthol with respect to the total amount of the composition according to the present invention is 0.01% by mass or more and 1.0% by mass or less. If the ratio is 0.01% by mass or more, a sufficient refreshing feeling can be more reliably imparted to the composition, and the adsorption of cetylpyridinium chloride to teeth and oral mucosa may be promoted. On the other hand, if the ratio is too high, although depending on the amount of surfactant and other oil-soluble components used, menthol may not be completely dissolved in the aqueous solvent and phase separation may occur. Less than mass%. As the said ratio, 0.02 mass% or more is preferable, 0.05 mass% or more is more preferable, 0.08 mass% or more is more preferable, 0.8 mass% or less is preferable, 0.5 mass% The following is more preferable, and 0.2% by mass or less is more preferable.

Component (d): Aqueous solvent The composition according to the present invention is a transparent liquid used for the oral cavity. Therefore, the solvent used in the composition of the present invention is an aqueous solvent that is harmless or less harmful to the living body.

  In the present invention, the aqueous solvent refers to water or a mixed solvent of water and ethanol. The kind of water here is not particularly limited, and any of distilled water, pure water, ultrapure water, purified water, tap water, and the like can be used.

  The content of the aqueous solvent with respect to the total amount of the composition according to the present invention is 60% by mass or more and 99.8% by mass or less. When the proportion is 60% by mass or more, the composition according to the present invention can be sufficiently maintained in a liquid state. On the other hand, if the proportion is too high, the proportion of other essential components must be relatively low, and the effects of each component may not be sufficiently exhibited. Therefore, the proportion is 99.8 masses. % Or less.

Component (e): Polyoxyethylene hydrogenated castor oil having an average added mole number of ethylene oxide of 40 or more and 100 or less The component (e) is incorporated into a liquid composition when a relatively large amount of oil-soluble components is blended. It is a component for stably dispersing and maintaining transparency.

  The content of the component (e) relative to the total amount of the composition according to the present invention is 0.01% by mass or more and 0.3% by mass or less and not more than the compounding amount of the component (b). If the said ratio is 0.01 mass% or more, it becomes possible to disperse | distribute an oil-soluble component more reliably, and can maintain the transparency of a composition. On the other hand, if the ratio is too high, the cetylpyridinium chloride, which is the main medicinal component of the composition of the present invention, may be excessively stabilized in the micelle and the amount of adsorption onto the teeth may be reduced. The ratio is not more than the amount of component (b) and not more than 0.3% by mass. The component (e) is preferably 3/4 or less of the blending amount of the component (b), more preferably 1/2 or less of the blending amount of the component (b). Moreover, as said ratio, 0.2 mass% or less is preferable on the assumption that it is the compounding quantity or less of a component (b), and 0.1 mass% or less is more preferable.

  Further, the total ratio of the component (b) and the component (e) to the component (a) ([component (b) + component (e)] / component (a)) is 0.6 or more and 4.4 or less. It is preferable to adjust the component constitution so as to be. If the ratio is 0.6 or more, the component (a) (cetylpyridinium chloride) can be more stably and stably dispersed in the composition even when an oil-soluble component such as menthol is present. On the other hand, when the ratio is too high, the component (a) (cetylpyridinium chloride) may be excessively stabilized in the micelle and the amount of adsorption onto the teeth may be reduced. Therefore, the ratio is 4.4 or less. And The ratio is more preferably 4.0 or less, further preferably 3.0 or less, and particularly preferably 2.0 or less.

  Furthermore, the total amount of the component (b) and the component (e) with respect to the total amount of the composition according to the present invention is preferably 0.02% by mass or more and 0.7% by mass or less. If the ratio is 0.02% by mass or more, the liquid composition according to the present invention can be more reliably maintained transparent. On the other hand, if the ratio is too high, the amount of cetylpyridinium chloride adsorbed on the teeth may be reduced as described above, so the ratio is set to 0.7% by mass or less. As the said ratio, 0.05 mass% or more is more preferable, 0.1 mass% or more is further more preferable, 0.5 mass% or less is more preferable, and 0.3 mass% or less is further more preferable.

Component (f): Oil-soluble component other than menthol In addition to menthol, an oil-soluble component generally blended into the oral composition may be added to the composition of the present invention. The oil-soluble component means a compound having a solubility in water at 20 ° C. of 1 [g / g-H ₂ O] or less, specifically, an oil-soluble fragrance other than menthol, an oil-soluble alcohol, and an oil-soluble preservative. An agent. One of these oil-soluble components may be selected and used, or two or more may be selected and used in combination.

  The content of the oil-soluble component (e) with respect to the total amount of the composition according to the present invention (single amount in the case of a single component and the total amount when two or more types are included) is 0.001% by mass or more, 1 0.0 mass% or less is preferable. If the said content is 0.001 mass% or more, the addition effect of an oil-soluble component can be exhibited more reliably. On the other hand, if the content is too large, phase separation may occur with respect to the aqueous solvent and the appearance properties may be lowered. Therefore, the content is preferably 1.0% by mass or less. As said content, 0.01 mass% or more is more preferable, 0.5 mass% or less is more preferable, 0.3 mass% or less is further more preferable, 0.2 mass% or less is especially preferable.

  The oil-soluble medicinal component used in the present invention is not particularly limited. For example, a halogenated diphenyl ether such as triclosan (2 ′, 4,4′-trichloro-2-hydroxy-diphenyl ether) or a phenol type such as isopropylmethylphenol. Bactericides; thiol-based bactericides such as hinokitiol; blood circulation promoters such as dl-α-tocopherol acetate, tocopherol succinate and tocopherol nicotinate; and anti-inflammatory agents such as glycyrrhetinic acid.

  The preferred content of the above oil-soluble medicinal ingredients with respect to the total amount of the composition (single amount when used alone, and the total amount when containing two or more types) is not particularly limited, but, for example, 0.001% by mass or more 1.0 mass% or less. If the said content is 0.001 mass% or more, the addition effect of an oil-soluble medicinal ingredient can be more reliably exhibited. On the other hand, if the content is too large, the oral mucosa may be irritating, so the content is preferably 1.0% by mass or less. As said content, 0.005 mass% or more is more preferable, 0.5 mass% or less is more preferable, 0.3 mass% or less is further more preferable, 0.2 mass% or less is especially preferable.

  Examples of oil-soluble fragrances other than menthol are not particularly limited. Eugenol, anethole, limonene, ocimene, methyl acetate, citronenyl acetate, cineole, ethyl linalool, crocodile, thyme, nutmeg, spearmint oil, peppermint oil, lemon oil, orange oil, sage oil, rosemary oil, cinnamon oil , Perilla oil, winter green oil, clove oil, eucalyptus oil, pimento oil, tea tree oil, tabana oil, star anise oil, fennel oil, diatom oil, basil oil, coriander oil, grapefruit oil, peppermint oil And the like. Among these, in addition to menthol, spearmint oil, peppermint oil, and menthone can be preferably used.

  The preferred content of the oil-soluble fragrance with respect to the total amount of the composition (single amount in the case of a single component and the total amount when two or more types are included) is not particularly limited, for example, 0.01% by mass or more, It can be 1.0 mass% or less. If the said content is 0.01 mass% or more, the addition effect of an oil-soluble fragrance | flavor will be more reliably exhibited. If the content is too high, the flavor becomes strong and not only the preference is lowered, but irritation to the oral mucosa and the nasal mucosa may occur, so the content is 1.0% by mass or less. It is preferable to do. As said content, 0.02 mass% or more is more preferable, 0.04 mass% or more is further more preferable, 0.8 mass% or less is more preferable, and 0.5 mass% or less is further more preferable.

  The oil-soluble alcohol used in the present invention is not particularly limited, and examples thereof include hexanol, octanol, 2-ethyl-1-hexanol, and decanol. Of these, 1-hexanol, 1-octanol, 2-ethyl-1-hexanol, and 1-decanol are preferable, and 1-hexanol, 1-octanol, and 1-decanol are more preferable. Are 1-hexanol and 1-octanol.

  The preferred content of the oil-soluble alcohols relative to the total amount of the composition (single amount when used alone, and the total amount when containing two or more types) is, for example, 0.01% by mass or more and 1.0% by mass. % Or less. If the said content is 0.01 mass% or more, the addition effect of oil-soluble alcohol will fully be exhibited. On the other hand, if the content is too high, not only is the flavor reduced and the palatability is lowered, but irritation to the oral mucosa may occur, so the content should be 1.0% by mass or less. Is preferred. As said content, 0.05 mass% or more is more preferable, 0.5 mass% or less is more preferable, and 0.2 mass% or less is further more preferable.

  The oil-soluble preservative used in the present invention is not particularly limited. For example, methyl p-hydroxybenzoate, ethyl p-hydroxybenzoate, propyl p-hydroxybenzoate, butyl p-hydroxybenzoate, p-hydroxy And p-hydroxybenzoic acid esters such as isopropyl benzoate and isobutyl p-hydroxybenzoate. Of these, it is particularly preferable to use methyl p-hydroxybenzoate (methylparaben).

  The preferred content of the oil-soluble preservative with respect to the total amount of the composition (single amount when used alone, and the total amount when containing two or more types) is not particularly limited. For example, 0.01% by mass or more 1.0 mass% or less. If the said content is 0.01 mass% or more, the addition effect of an oil-soluble preservative will be more reliably exhibited. On the other hand, if the content is too high, not only is the flavor reduced and the palatability is lowered, but irritation to the oral mucosa may occur, so the content should be 1.0% by mass or less. Is preferred. As said content, 0.05 mass% or more is more preferable, 0.5 mass% or less is more preferable, and 0.2 mass% or less is further more preferable.

Other components In addition to the above components (a) to (f), the oral composition of the present invention loses the effects of the present invention by adding additives that are usually used in oral compositions according to the dosage form. You may add suitably in the range which is not.

  For example, as the surfactant, at least one of a nonionic surfactant other than the component (b) and the component (e), an anionic surfactant, or a zwitterionic surfactant can be blended.

  For example, as a nonionic surfactant, in addition to polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene sterol, polyglycerin fatty acid ester, sucrose fatty acid ester, maltose fatty acid Esters, sugar fatty acid esters such as lactose fatty acid esters, fatty acid alkanolamides, sorbitan fatty acid esters, fatty acid monoglycerides, polyoxyethylene alkyl ethers, polyoxyethylene alkyl phenyl ethers, diethyl sebacate, polyoxyethylene sorbite fatty acid esters, polyethylene glycol fatty acids Ester, polyoxyethylene lanolin, polyoxyethylene lanolin alcohol, alkyl glucoside, poly Such as alkoxy polyoxypropylene block copolymers. These nonionic surfactants can be used alone or in combination of two or more.

  Examples of the anionic surfactant used in the present invention include sulfate ester salts such as sodium lauryl sulfate and sodium polyoxyethylene lauryl ether sulfate; sulfosuccinate such as sodium lauryl sulfosuccinate and sodium polyoxyethylene lauryl ether sulfosuccinate; Examples include acyl amino acid salts such as cocoyl sarcosine sodium and sodium lauroylmethylalanine; cocoyl methyl taurine sodium and the like. These anionic surfactants can be used alone or in combination of two or more.

  Examples of the zwitterionic surfactant used in the present invention include betaine acetate type activators such as lauryldimethylaminoacetic acid betaine, coconut oil fatty acid amidopropyldimethylaminoacetic acid betaine, and N-cocoyl-N-carboxymethyl-N-hydroxy. Examples include imidazoline type activators such as ethylethylenediamine sodium, and amino acid type activators such as N-lauryldiaminoethylglycine. These zwitterionic surfactants can be used alone or in combination of two or more.

  In the present invention, a binder can be further blended. Examples of the binder include cellulose derivatives such as sodium carboxymethylcellulose, carboxymethylethylcellulose salt, hydroxyethylcellulose, hydroxypropylcellulose, and hydroxypropylmethylcellulose; microbially produced polymers such as xanthan gum and gellan gum; tragacanth gum, karaya gum, arabiya gum, carrageenan, Natural polymers such as dextrin or natural rubbers; synthetic polymers such as polyvinyl alcohol and polyvinylpyrrolidone; and cationic binders such as O- [2-hydroxy-3- (trimethylammonio) propyl] hydroxyethylcellulose chloride. It is done. These binders can be used alone or in combination of two or more.

  In the present invention, a sweetener can be further blended. Examples of the sweetening agent include saccharin, saccharin sodium, acesulfame potassium, stevia extract, stevioside, neohesperidyl dihydrochalcone, glycyrrhizin, perilartin, thaumatin, aspartylphenylalanine methyl ester, methoxycinnamic aldehyde, palatinose, palatinit, erythritol, Examples include maltitol, xylitol, and lactitol. These sweeteners can be used alone or in combination of two or more.

  In the present invention, a wetting agent can be further blended. Examples of the wetting agent include glycerin, ethylene glycol, propylene glycol, butanediol, pentanediol, hexanediol, sorbit, polyethylene glycol, polypropylene glycol, 1,2-octanediol, 1,8-octanediol, 2,3- Octanediol, 2,4-octanediol, 2-ethyl-1,3-hexanediol, 2,2,4-trimethyl-1,3-pentanediol, 2,5-dimethyl-2,5-hexanediol, etc. Can be mentioned. These wetting agents can be used alone or in combination of two or more.

  In the present invention, a preservative other than the oil-soluble preservative can be further blended. Examples of such preservatives include benzoates such as sodium benzoate and phenols such as phenoxyethanol. These preservatives can be used alone or in combination of two or more.

  In the present invention, a pH adjuster may be further blended to adjust the pH of the oral composition according to the present invention to an appropriate range. The pH in the present invention is not particularly limited as long as it can be used in the oral cavity, but generally it is preferably pH 3.0 or more and 10.5 or less, more preferably pH 5.5 or more and 8.0 or less. More preferably, the pH is 6.0 or more and 7.5 or less.

  Examples of the pH adjuster used in the present invention include citric acid, phosphoric acid, malic acid, gluconic acid, maleic acid, aspartic acid, succinic acid, glucuronic acid, fumaric acid, glutamic acid, adipic acid, and salts thereof. In addition, hydrochloric acid, sodium hydroxide, potassium hydroxide, sodium silicate and the like can be mentioned. These pH adjusters can be used alone or in combination of two or more.

  In the present invention, cetylpyridinium chloride, which is an active ingredient, and medicinal ingredients other than the oil-soluble medicinal ingredients can also be blended. Examples of such medicinal components include cationic fungicides such as chlorhexidine gluconate, benzethonium chloride, and benzalkonium chloride; amphoteric fungicides such as dodecyldiaminoethylglycine; dextranase, amylase, protease, mutanase, lysozyme, lysis Enzymes such as enzymes (Litec Enzymes); Glycyrrhizinates such as dipotassium glycyrrhizinate as anti-inflammatory agents; Tranexamic acid and epsilon aminocaproic acid as antiplasmin agents; Ascorbic acid as bleeding remedy; Allantoin as tissue repair agent; Examples of the remineralizing agent include fluorine compounds such as sodium fluoride. In addition to the above, plant extracts extracted with a water-soluble solvent, chlorophyll, sodium chloride, zinc chloride and the like can also be mentioned, and these can be used alone or in combination of two or more.

  In the present invention, N-long chain acyl basic amino acid lower alkyl ester or a salt thereof can be further blended for the purpose of further improving the adsorption of cetylpyridinium chloride. The basic amino acid moiety constituting the N-long-chain acyl basic amino acid lower alkyl ester is preferably ornithine, lysine or arginine, and these may be either optically active or racemic. Examples of the acyl group constituting the N-long-chain acyl basic amino acid lower alkyl ester include saturated or unsaturated fatty acid residues derived from saturated or unsaturated having 8 to 22 carbon atoms. Specific examples include single fatty acid residues such as lauroyl group, myristyl group, palmitoyl group and stearoyl group; natural mixed fatty acid residues such as coconut oil fatty acid residue and cow oil fatty acid residue. . Examples of the lower alkyl ester constituting the N-long chain acyl basic amino acid lower alkyl ester include methyl ester, ethyl ester, propyl ester and the like.

  Examples of the salt of the N-long chain acyl basic amino acid lower alkyl ester include inorganic acid salts such as hydrochloride and sulfate; glutamate, pyroglutamate, acetate, tartrate, citrate and fatty acid salt. And organic acid salts such as acidic amino acid salts. In particular, glutamate, pyroglutamate, acetate, and citrate are preferable.

  Preferable N-long chain acyl basic amino acid lower alkyl ester or a salt thereof used in the present invention includes, for example, N-cocoyl-L-arginine ethyl ester / pyrrolidone carboxylate (CAE), N-lauroyl-L- Examples include arginine ethyl ester and pyrrolidone carboxylate.

  The form (dosage form) of the composition for oral cavity according to the present invention is not particularly limited as long as it is a transparent liquid. For example, it can be set as oral liquid compositions, such as a liquid dentifrice, a mouthwash, a liquid agent, a spray agent, and a moisturizer, which does not contain an insoluble component substantially. Moreover, as long as it can be said that it is liquid, it may have a certain amount of viscosity, or it may be a gel.

  The composition for oral cavity which concerns on this invention can be manufactured by a conventional method. That is, it can be easily prepared only by mixing an aqueous solvent and other components.

  EXAMPLES Hereinafter, the present invention will be described more specifically with reference to examples. However, the present invention is not limited by the following examples, but may be appropriately modified within a range that can meet the purpose described above and below. Of course, it is possible to implement them, and they are all included in the technical scope of the present invention.

Production Example An oral composition having the composition shown in Table 1 was prepared. Specifically, glycerin and propylene glycol were mixed in an appropriate amount of purified water, each component was added and mixed well, and then purified water was further added and mixed. Next, an appropriate amount of citric acid or sodium citrate was added as a pH adjuster to adjust the pH of the composition to a range of 5.8 to 6.2. In Table 1, the numerical values in parentheses mean the average added mole number of ethylene oxide (EO).

  Each composition thus obtained was evaluated for appearance properties and adsorption of cetylpyridinium chloride on the tooth surface by the following methods.

Test Example 1: Appearance property evaluation method The appearance of the composition immediately after the preparation was visually observed, and the transparency as a liquid preparation was evaluated according to the following criteria.
○: colorless and transparent ×: cloudiness or phase separation

  In addition, the following adsorption | suction evaluation test was not done for the thing of external appearance property x. In this case, “-” is added to the column of “CPC (cetylpyridinium chloride) adsorption amount” in Table 1 described later.

Test Example 2: Method for evaluating adsorption of cetylpyridinium chloride to tooth surface As a model of tooth enamel, hydroxyapatite powder (Hydroxyapatite Bio-Gel (registered trademark) HTP Gel manufactured by BIO-RAD Lab., USA) (hereinafter, “ HA ”is abbreviated.) 50 mg of a human saliva sterilized with ultraviolet rays was immersed in 2 mL of human saliva at 37 ° C. for 15 hours, and a pellicle (saliva protein) layer was formed on the HA surface. Thereafter, the mixture was centrifuged at 3000 rpm for 10 minutes, and the supernatant was removed.

  Next, 2 mL of each sample solution to be tested was added to the HA that had been subjected to the above treatment and immersed for 15 minutes at 37 ° C., and then centrifuged at 3000 rpm for 10 minutes to remove the supernatant. Next, 2 ml of distilled water was added to the HA that had been treated and stirred, and then the operation of centrifuging at 3000 rpm for 10 minutes and removing the supernatant was repeated twice. Next, 5 mL of an extract (10 mM sodium lauryl sulfate-40 mM citrate buffer (pH 3.0) / acetonitrile = 25/75 (volume ratio)) is added to the HA thus treated, and cetyl chloride adsorbed on the HA. Pyridinium (CPC) was extracted. After the above operation was repeated twice, the amount was determined by HPLC and the amount (μg) of CPC adsorbed on 50 mg of HA was determined. The conditions for HPLC are the same as those described in Experiment 1 of Patent Document 1.

  These results are also shown in Table 1. Table 1 includes a column for comprehensive evaluation, and when the determination was made based on the following criteria, a comprehensive evaluation of “◎” or “◯” was accepted. In addition, the acceptance standard of the CPC adsorption amount in the present example is higher than that of Patent Document 1 described above.

(Comprehensive evaluation)
◎: Appearance property is ◯ and CPC adsorption amount is 840 μg or more ○: Appearance property is ◯ and CPC adsorption amount is 820 μg or more and less than 840 μg ×: Appearance property is × or Appearance property is ○ And the adsorption amount of CPC is less than 820μg

  As shown in Table 1, in Comparative Example 1 containing only polyoxyethylene hydrogenated castor oil having an average addition mole number of ethylene oxide of 5 as a surfactant and Comparative Example 2 not containing polyoxyethylene hydrogenated castor oil, each component Even after mixing, the composition became cloudy, and when it was allowed to stand for a while, the oil-soluble component phase separated into the upper part.

  Further, in the case of Comparative Example 3 containing only polyoxyethylene hydrogenated castor oil having an average added mole number of ethylene oxide of 80 as a surfactant, the oil-soluble component could be stably dispersed, and the composition became transparent, The amount of adsorption of CPC (cetylpyridinium chloride) was not sufficient.

  On the other hand, in Examples 1 to 11 containing a predetermined ratio of polyoxyethylene hydrogenated castor oil and menthol having an average added mole number of ethylene oxide of 10 or more and 30 or less, each component is satisfactorily stably dispersed in the composition. In addition to being transparent, the amount of adsorbed CPC was sufficient.

  As described above, the oral transparent liquid composition according to the present invention is transparent and excellent in appearance as a product, and has a high bactericidal action against oral bacteria causing caries, gingivitis, and the like. It was demonstrated that CPC has a very high adsorption effect on the tooth surface and has an excellent anti-plaque formation action.

  Hereinafter, although the preferable formulation example of the composition for oral cavity which concerns on this invention is given, this invention is not limited to the following formulation example. The unit of the amount is mass%.

Formulation Example 1 (Mouthwash)
Ingredient Blending amount Cetylpyridinium chloride 0.1
Polyoxyethylene (30) hydrogenated castor oil 0.25
Polyoxyethylene (60) hydrogenated castor oil 0.05
β-glycyrrhetinic acid (oil-soluble medicinal component) 0.01
l-Menthol 0.1
Methyl paraoxybenzoate 0.1
Glycerin 10
Propylene glycol 3
Saccharin sodium 0.01
pH adjuster (citric acid, sodium citrate) appropriate amount Purified water remaining
Total 100

Formulation Example 2 (Mouthwash)
Ingredients Amount
Cetylpyridinium chloride 0.2
Polyoxyethylene (20) hydrogenated castor oil 0.2
Polyoxyethylene (80) hydrogenated castor oil 0.1
Isopropylmethylphenol (oil-soluble medicinal component) 0.05
l-Menthol 0.2
Glycerin 9
Ethanol 7
Saccharin sodium 0.01
pH adjuster (citric acid, sodium citrate) appropriate amount Purified water remaining
Total 100

Formulation Example 3 (Liquid Dentifrice)
Ingredient Blending amount Cetylpyridinium chloride 0.3
Polyoxyethylene (20) hydrogenated castor oil 0.13
Polyoxyethylene (60) hydrogenated castor oil 0.05
Peppermint flavor (containing 10% l-menthol) 0.1
Sorbitol 10
1,3-butylene glycol 5
Saccharin sodium 0.01
pH adjuster (sodium dihydrogen phosphate,
Sodium monohydrogen phosphate) Appropriate amount Purified water balance
Total 100

Formulation example 4 (liquid dentifrice)
Ingredient Blending amount Cetylpyridinium chloride 0.3
Polyoxyethylene (20) hydrogenated castor oil 0.4
Polyoxyethylene (40) hydrogenated castor oil 0.3
Hinokitiol (oil-soluble medicinal ingredient) 0.01
l-Menthol 0.3
Glycerin 10
Ethanol 3
Saccharin sodium 0.01
pH adjuster (citric acid, sodium citrate) appropriate amount Purified water remaining
Total 100

Formulation example 5 (gel dentifrice)
Ingredient Blending amount Cetylpyridinium chloride 0.03
Polyoxyethylene (10) hydrogenated castor oil 0.01
Polyoxyethylene (60) hydrogenated castor oil 0.01
l-Menthol 0.01
Hydroxyethyl cellulose 1
Glycerin 30
Propylene glycol 5.0
Saccharin sodium 0.02
pH adjuster (citric acid, sodium citrate) appropriate amount Purified water remaining
Total 100

Formulation Example 6 (Gel for oral application)
Ingredient Blending amount Cetylpyridinium chloride 0.3
Polyoxyethylene (10) hydrogenated castor oil 0.3
Polyoxyethylene (60) hydrogenated castor oil 0.2
Tocopherol nicotinate (oil-soluble medicinal ingredient) 0.2
l-Menthol 0.2
Hydroxyethyl cellulose 3
Glycerin 30
Propylene glycol 5
Saccharin sodium 0.02
pH adjuster (citric acid, sodium citrate) appropriate amount Purified water remaining
Total 100

Formulation example 7 (gel dentifrice)
Ingredient Blending amount Cetylpyridinium chloride 0.04
Polyoxyethylene (20) hydrogenated castor oil 0.4
Chlorhexidine hydrochloride (oil-soluble medicinal ingredient) 0.05
Peppermint oil (containing 20% l-menthol) 1
Potassium nitrate 5
Sodium fluoride 0.2
Glycerin 25
Propylene glycol 3
Hydroxypropyl methylcellulose 3
pH adjuster (citric acid, sodium citrate) appropriate amount Purified water remaining
Total 100

Formulation Example 8 (mouse spray)
Ingredients Amount
Cetylpyridinium chloride 0.01
Polyoxyethylene (20) hydrogenated castor oil 0.05
Orange oil (oil-soluble fragrance) 0.2
l-Menthol 0.05
Ethanol 35
Glycerin 10
Saccharin sodium 0.1
pH adjuster (citric acid, sodium citrate) appropriate amount Purified water remaining
Total 100

Formulation Example 9 (mouse spray)
Ingredients Amount
Cetylpyridinium chloride 0.3
Polyoxyethylene (20) hydrogenated castor oil 0.2
Lemon oil (oil-soluble fragrance) 0.05
l-Menthol 0.15
Ethanol 30
Glycerin 5
Saccharin sodium 0.1
pH adjuster (citric acid, sodium citrate) appropriate amount Purified water remaining
Total 100

Formulation Example 10 (oral application gel)
Ingredients Amount
Cetylpyridinium chloride 0.02
Polyoxyethylene (20) hydrogenated castor oil 0.04
Polyoxyethylene (60) hydrogenated castor oil 0.01
l-Menthol 0.02
Methyl paraoxybenzoate 0.005
Sorbitol 30
Glycerin 30
Hyaluronic acid 0.1
Hydroxyethyl cellulose 1
pH adjuster (sodium dihydrogen phosphate,
Sodium monohydrogen phosphate) Appropriate amount Purified water balance
Total 100

Formulation Example 11 (oral moisturizer)
Ingredients Amount
Cetylpyridinium chloride 0.1
Polyoxyethylene (20) hydrogenated castor oil 0.34
Polyoxyethylene (60) hydrogenated castor oil 0.1
Tocopherol nicotinate (oil-soluble medicinal ingredient) 0.05
Spearmint oil 0.3
l-Menthol 0.01
Trimethylglycine 0.5
Sorbitol 20
Glycerin 10
Saccharin sodium 0.2
Purified water balance
Total 100

Claims (4)

A transparent liquid composition for oral cavity comprising the following component (a), component (b), component (c) and component (d).
Component (a): 0.01% by mass or more and 0.3% by mass or less of cetylpyridinium chloride Component (b): 0.01% by mass or more and 0.4% by mass or less of ethylene oxide having an average added mole number of 10 30 or less polyoxyethylene hydrogenated castor oil Component (c): 0.01% by mass or more and 1.0% by mass or less menthol Component (d): 60% by mass or more and 99.8% by mass or less aqueous solvent Furthermore, the transparent liquid composition for oral cavity of Claim 1 containing the following component (e).
Component (e): Polyoxyethylene hydrogenated castor oil having an average added mole number of ethylene oxide of not less than 0.01% by mass and not more than 0.3% by mass and not more than the blending amount of component (b) of not less than 40 and not more than 100   The transparent liquid composition for oral cavity according to claim 1 or 2, wherein the total ratio of the component (b) and the component (e) to the component (a) is 0.6 or more and 4.4 or less. Furthermore, the transparent liquid composition for oral cavity in any one of Claims 1-3 containing the following component (f).
Component (f): One or more oil-soluble ingredients selected from oil-soluble medicinal ingredients, oil-soluble fragrances other than menthol, oil-soluble alcohols, and oil-soluble preservatives